Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CoronaVac induces lower neutralising activity against variants of concern than natural infection.
Vacharathit V, Aiewsakun P, Manopwisedjaroen S, Srisaowakarn C, Laopanupong T, Ludowyke N, Phuphuakrat A, Setthaudom C, Ekronarongchai S, Srichatrapimuk S, Wongsirisin P, Sangrajrang S, Imsuwansri T, Kirdlarp S, Nualkaew S, Sensorn I, Sawaengdee W, Wichukchinda N, Sungkanuparph S, Chantratita W, Kunakorn M, Rojanamatin J, Hongeng S, Thitithanyanont A. Vacharathit V, et al. Among authors: setthaudom c. Lancet Infect Dis. 2021 Oct;21(10):1352-1354. doi: 10.1016/S1473-3099(21)00568-5. Epub 2021 Aug 26. Lancet Infect Dis. 2021. PMID: 34454652 Free PMC article. No abstract available.
SARS-CoV-2 neutralizing antibodies decline over one year and patients with severe COVID-19 pneumonia display a unique cytokine profile.
Vacharathit V, Srichatrapimuk S, Manopwisedjaroen S, Kirdlarp S, Srisaowakarn C, Setthaudom C, Inrueangsri N, Pisitkun P, Kunakorn M, Hongeng S, Sungkanuparph S, Thitithanyanont A. Vacharathit V, et al. Among authors: setthaudom c. Int J Infect Dis. 2021 Nov;112:227-234. doi: 10.1016/j.ijid.2021.09.021. Epub 2021 Sep 15. Int J Infect Dis. 2021. PMID: 34536610 Free PMC article.
External quality assessment scheme for HbA1c assays in Thailand: A 5-year experience.
Suparak S, Pratumvinit B, Ngueanchanthong K, Unpol P, Thanomsakyuth A, Setthaudom C, Kunakorn M, Rojanawiwat A, Uppapong B. Suparak S, et al. Among authors: setthaudom c. Pract Lab Med. 2022 Jun 27;31:e00288. doi: 10.1016/j.plabm.2022.e00288. eCollection 2022 Aug. Pract Lab Med. 2022. PMID: 35814312 Free PMC article.
Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants.
Seree-Aphinan C, Chanprapaph K, Rattanakaemakorn P, Setthaudom C, Suangtamai T, Pomsoong C, Ratanapokasatit Y, Suchonwanit P. Seree-Aphinan C, et al. Among authors: setthaudom c. Front Med (Lausanne). 2021 Dec 8;8:769845. doi: 10.3389/fmed.2021.769845. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34957149 Free PMC article.
A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants.
Bruminhent J, Autto S, Rotjanapan P, Ngarmjanyaporn P, Bushyakanist A, Kirdlarp S, O-Charoen P, Setthaudom C, Pisitkun P. Bruminhent J, et al. Among authors: setthaudom c. Open Forum Infect Dis. 2021 May 16;8(6):ofab248. doi: 10.1093/ofid/ofab248. eCollection 2021 Jun. Open Forum Infect Dis. 2021. PMID: 34189173 Free PMC article.
A real-world prospective cohort study of immunogenicity and reactogenicity of ChAdOx1-S[recombinant] among patients with immune-mediated dermatological diseases.
Chanprapaph K, Seree-Aphinan C, Rattanakaemakorn P, Pomsoong C, Ratanapokasatit Y, Setthaudom C, Thitithanyanont A, Suriyo A, Suangtamai T, Suchonwanit P; COVIDVAC-DERM study group. Chanprapaph K, et al. Among authors: setthaudom c. Br J Dermatol. 2023 Feb 10;188(2):268-277. doi: 10.1093/bjd/ljac045. Br J Dermatol. 2023. PMID: 36637102
23 results